Alectinib

CHEMBL1738797 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

482.6 g/mol

LogP

5.2

Phase

4

A targeted therapy that selectively blocks an abnormal protein called ALK that drives the growth of certain cancers, particularly non-small cell lung cancer with ALK gene rearrangements. By precisely inhibiting this signaling pathway, alectinib helps stop tumor growth and has good penetration into the brain, making it effective against cancer that has spread there.

Masse moléculaire

482,6000 g/mol

LogP

5,20

TPSA

72,40 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Non-Small Cell Lung Cancer Melanoma Lymphoma Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O

InChI

InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3

Molecular Formula

C30H34N4O2

HBD / HBA

1 / 5

Liaisons Rotatives

3

Atomes Lourds

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A targeted therapy that selectively blocks an abnormal protein called ALK that drives the growth of certain cancers, particularly non-small cell lung cancer with ALK gene rearrangements. By precisely inhibiting this signaling pathway, alectinib helps stop tumor growth and has good penetration into the brain, making it effective against cancer that has spread there.

Yes, Alectinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1738797. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 49806720. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Alectinib sur PillFYI

Structure

Données Clés

Formule: C30H34N4O2
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.